Abstract: Novel purine derivatives are described as agents for treating autoimmune diseases as well as a method of manufacture and pharmaceutical compositions as well as novel intermediates in the manufacture thereof.
Type:
Grant
Filed:
September 29, 1988
Date of Patent:
May 1, 1990
Assignee:
Warner-Lambert Company
Inventors:
Jagadish C. Sircar, Charles F. Schwender, Mark J. Suto
Abstract: The present invention is various 7-deazaguanines having activity as immunomodulators. Also included are pharmaceutical compositions and methods of use thereof.
Abstract: The present invention relates to novel enolamide type compounds, pharmaceutical compositions, and methods of use thereof, useful in the treatment of diseases in which products of lipoxygenase enzyme activity or the action of leukotrienes contribute to the pathological condition.
Type:
Grant
Filed:
November 16, 1987
Date of Patent:
May 1, 1990
Assignee:
Warner-Lambert Company
Inventors:
Mary E. Carethers, Wiaczeslaw A. Cetenko, David T. Connor, Elizabeth A. Johnson, John S. Kiely, Charles F. Schwender, Jagadish C. Sircar, Roderick J. Sorenson, Paul C. Unangst, Robert F. Bruns
Abstract: Novel purine derivatives are described as agents for treating autoimmune diseases as well as a method of manufacture and pharmaceutical compositions as well as novel intermediates in the manufacture thereof.
Type:
Grant
Filed:
September 29, 1989
Date of Patent:
April 17, 1990
Assignee:
Warner-Lambert Company
Inventors:
Jagadish C. Sircar, Charles F. Schwender, Mark J. Suto
Abstract: Selected analogs of nipecotic acid are the novel compounds of the present invention. The analogs are GABA uptake inhibitors for use to treat epilepsy and, thus, the invention is also pharmaceutical compositions and methods of use therefor.
Abstract: Novel benzothiophenes having antiallergic activity and both novel and other selected benzothiophenes having activity for treating acute respiratory distress syndrome. The benzothiophenes of the present invention are particularly 2-tetrazolylcarboxamides of the benzothiophenes.
Type:
Grant
Filed:
June 27, 1988
Date of Patent:
March 20, 1990
Assignee:
Warner-Lambert Company
Inventors:
David T. Connor, Michael D. Mullican, Roderick J. Sorenson, David O. Thueson
Abstract: The present invention is 3,5-substituted, isoxazoles, pyrazoles, isothiazoles, and analogs thereof having 5-lipoxygenase or cyclooxygenase inhibiting activity or as a sunscreen.
Type:
Grant
Filed:
September 21, 1988
Date of Patent:
October 31, 1989
Assignee:
Warner-Lambert Company
Inventors:
Thomas R Belliotti, David T. Connor, Daniel L. Flynn, Catherine R. Kostlan, Donald E. Nies
Abstract: The present invention relates to novel enolamide type compounds, pharmaceutical compositions, and method of use thereof, useful in the treatment of diseases in which products of lipoxygenase enzyme activity or the action of leukotrienes contribute to the pathological condition.
Type:
Grant
Filed:
March 4, 1988
Date of Patent:
October 17, 1989
Assignee:
Warner-Lambert Company
Inventors:
Mary E. Carethers, Wiaczeslaw A. Centenko, David T. Connor, Elizabeth A. Johnson, John S. Kiely, Charles F. Schwender, Jagadish C. Sircar, Roderick J. Sorenson, Paul C. Unangst, Robert F. Bruns
Abstract: Novel guanine derivatives are described as agents for treating autoimmune diseases as well as a method of manufacture and pharmaceutical compositions thereof.
Type:
Grant
Filed:
October 14, 1987
Date of Patent:
October 17, 1989
Assignee:
Warner-Lambert Company
Inventors:
Jagadish C. Sircar, Catherine R. Brungardt, Charles F. Schwender
Abstract: The present invention relates to novel enolamide type compounds, pharmaceutical compositions, and methods of use thereof, useful in the treatment of diseases in which products of lipoxygenase enzyme activity or the action of leukotrienes contribute to the pathological condition.
Type:
Grant
Filed:
March 9, 1988
Date of Patent:
September 19, 1989
Assignee:
Warner-Lambert Company
Inventors:
Mary E. Carethers, Wiaczeslaw A. Cetenko, David T. Connor, Elizabeth A. Johnson, John S. Kiely, Charles F. Schwender, Jagadish C. Sircar, Roderick J. Sorenson, Paul C. Unangst, Robert F. Bruns
Abstract: The present invention relates to novel enolamide type compounds, pharmaceutical compositions, and methods of use thereof, useful in the treatment of diseases in which products of lipoxygenase enzyme activity or the action of leukotrienes contribute to the pathological condition.
Type:
Grant
Filed:
March 9, 1988
Date of Patent:
September 19, 1989
Assignee:
Warner-Lambert Company
Inventors:
Mary E. Carethers, Wiaczeslaw A. Cetenko, David T. Connor, Elizabeth A. Johnson, John S. Kiely, Charles F. Schwender, Jagadish C. Sircar, Roderick J. Sorenson, Paul C. Unangst, Robert F. Bruns
Abstract: The present invention relates to novel enolamide type compounds, pharmaceutical compositions, and methods of use thereof, useful in the treatment of diseases in which products of lipoxygenase enzyme activity or the action of leukotrienes contribute to the pathological condition.
Type:
Grant
Filed:
March 7, 1988
Date of Patent:
September 19, 1989
Assignee:
Warner-Lambert Company
Inventors:
Mary E. Carethers, Wiaczeslaw A. Cetenko, David T. Connor, Elizabeth A. Johnson, John S. Kiely, Charles F. Schwender, Jagadish C. Sircar, Roderick J. Sorenson, Paul C. Unangst, Robert F. Bruns
Abstract: The present invention relates to novel enolamide type compounds, pharmaceutical compositions, and methods of use thereof, useful in the treatment of diseases in which products of lipoxygenase enzyme activity or the action of leukotrienes contribute to the pathological condition.
Type:
Grant
Filed:
March 11, 1988
Date of Patent:
September 19, 1989
Assignee:
Warner-Lambert Company
Inventors:
Mary E. Carethers, Wiaczeslaw A. Cetenko, David T. Connor, Elizabeth A. Johnson, John S. Kiely, Charles F. Schwender, Jagadish C. Sircar, Roderick J. Sorenson, Paul C. Unangst, Robert F. Bruns
Abstract: Novel N.sup.6 -substituted-5'-oxidized adenosine analogs, and pharmaceutical compositions, methods of use or processes to make therefor. The novel adenosines have utility for the treatment of hypertension, coronary insufficiency, psychosis, pain, angina, and heart failure.
Abstract: Novel 6-substituted-2(1H)-quinoline and related compounds having usefulness as cardiotonic, antihypertensive, and antithrombotic (platelet aggregation inhibition) agents.
Abstract: (1R-endo) or (1S-endo)-N-bicyclo[2.2.1]heptyl adenosine and pharmaceutically acceptable acid addition salts having highly desirable antihypertensive properties and unexpected A.sub.1 and A.sub.2 receptor binding activity, processes for their manufacture and pharmaceutical compositions and methods for using said compounds and compositions.
Abstract: The present invention is for compounds having the formula of N-1H-tetrazol-5-yl-2-thiophenecarboxamides, N-1H-tetrazol-5-yl-2-pyrrolecarboxamides, N-1H-tetrazol-5-yl-2-furancarboxamides or analogs of each of the carboxamides. The compounds are useful for the treatment of allergic or inflammatory conditions or diseases. Thus, pharmaceutical compositions and methods of use are also the invention. Processes of preparation for the compounds are also the invention.
Type:
Grant
Filed:
February 16, 1988
Date of Patent:
April 25, 1989
Assignee:
Warner-Lambert Company
Inventors:
Wiaczeslaw A. Cetenko, David T. Connor, Michael D. Mullican, Roderick J. Sorenson
Abstract: Novel 4,5-dihydro-4,4-dialkyl-6-(substituted)phenyl-3(2H)-pyridazinones having unexpected activity for use as cardiotonic and antihypertensive agents.
Type:
Grant
Filed:
November 10, 1986
Date of Patent:
April 11, 1989
Assignee:
Warner-Lambert Company
Inventors:
Ila Sircar, James A. Bristol, Richard W. Skeean
Abstract: This invention relates to novel substituted derivatives of diimidazo[1,5-a:4',5'-d]pyridines and analogs thereof, which are useful for the treatment of hypertension, as well as, novel pharmaceutical compositions, methods of use, and as intermediates for preparing novel substituted derivatives of 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid and analogs thereof having antihypertensive activity.
Type:
Grant
Filed:
April 7, 1987
Date of Patent:
March 28, 1989
Assignee:
Warner-Lambert Company
Inventors:
C. John Blankley, John C. Hodges, John S. Kiely, Sylvester R. Klutchko